Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation

Archives of Medical Research
Cheng WangHui Zhang

Abstract

We undertook this study to investigate the effect of mesangial cells stimulated by immunoglobin A1 from IgAN on transforming growth factor-beta1 synthesis in podocytes. Jacalin affinity chromatography and Sephacryl S-200 molecular sieve chromatography were used to isolate IgA1 from blood of IgAN patients, which was then used as aggregated IgA1 (aIgA1). Podocytes were incubated with special mesangial medium. Real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA) were used, respectively, to measure TGF-beta1 mRNA expression and its protein concentration in medium. TGF-beta1 mRNA and its protein concentration in the medium of podocytes increased when exposed to the medium of mesangial cells, which were stimulated by IgA1 from IgAN patients. Angiotensinogen and angiotensin-converting enzyme (ACE) mRNAs, as well as angiotensin II, were also increased by the medium (p <0.05). Enalaprilat and valsartan partly lowered overproduction of TGF-beta1 mRNA and excreted protein of podocytes, whereas enalaprilat plus valsartan completely restored them to the level as control. These data suggest that mesangial cells stimulated by IgA1 from IgAN patients may excrete some material to facilitate TGF-beta1 synthesis...Continue Reading

References

Nov 10, 1994·The New England Journal of Medicine·W A Border, N A Noble
Nov 1, 1995·Kidney International·Z I NiemirR Waldherr
Dec 12, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·P ArrizabalagaC Ascaso
Mar 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C ZojaG Remuzzi
Jun 30, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D RussoM M Balletta
Mar 29, 2002·Kidney International·Kevin V LemleyBryan D Myers
Feb 9, 2005·Kidney International·Paul J M van der BoogMohamed R Daha
Dec 7, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Joon Ho SongMoon-Jae Kim
May 8, 2007·Biochemical and Biophysical Research Communications·Hiroyuki KoboriTatsuya Shoji
Oct 5, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jia-Xiang DingHai-Yan Wang
Dec 7, 2007·Clinical and Investigative Medicine. Médecine Clinique Et Experimentale·Cheng WangXueqing Yu

❮ Previous
Next ❯

Citations

Jul 30, 2014·Nature Reviews. Nephrology·Jean-Claude Davin, Rosanna Coppo
Mar 12, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Jean-Claude Davin
Apr 9, 2020·Frontiers in Medicine·Sheng Chang, Xiao-Kang Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Kidney International
Judy SavigeYan Yan Wang
The New England Journal of Medicine
A T TieboschE Zeppenfeldt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Mai Tuyet VuongLeonid Padyukov
© 2021 Meta ULC. All rights reserved